Back to Search Start Over

Potential of measured relative shifts in collision cross section values for biotransformation studies.

Authors :
Lanshoeft C
Schütz R
Lozac'h F
Schlotterbeck G
Walles M
Source :
Analytical and bioanalytical chemistry [Anal Bioanal Chem] 2024 Jan; Vol. 416 (2), pp. 559-568. Date of Electronic Publication: 2023 Dec 02.
Publication Year :
2024

Abstract

Ion mobility spectrometry-mass spectrometry (IMS-MS) separates gas phase ions due to differences in drift time from which reproducible and analyte-specific collision cross section (CCS) values can be derived. Internally conducted in vitro and in vivo metabolism (biotransformation) studies indicated repetitive shifts in measured CCS values (CCS <subscript>meas</subscript> ) between parent drugs and their metabolites. Hence, the purpose of the present article was (i) to investigate if such relative shifts in CCS <subscript>meas</subscript> were biotransformation-specific and (ii) to highlight their potential benefits for biotransformation studies. First, mean CCS <subscript>meas</subscript> values of 165 compounds were determined (up to n = 3) using a travelling wave IMS-MS device with nitrogen as drift gas ( <superscript>TW</superscript> CCS <subscript>N2, meas</subscript> ). Further comparison with their predicted values ( <superscript>TW</superscript> CCS <subscript>N2, pred</subscript> , Waters CCSonDemand) resulted in a mean absolute error of 5.1%. Second, a reduced data set (n = 139) was utilized to create compound pairs (n = 86) covering eight common types of phase I and II biotransformations. Constant, discriminative, and almost non-overlapping relative shifts in mean <superscript>TW</superscript> CCS <subscript>N2, meas</subscript> were obtained for demethylation (- 6.5 ± 2.1 Å <superscript>2</superscript> ), oxygenation (hydroxylation + 3.8 ± 1.4 Å <superscript>2</superscript> , N-oxidation + 3.4 ± 3.3 Å <superscript>2</superscript> ), acetylation (+ 13.5 ± 1.9 Å <superscript>2</superscript> ), sulfation (+ 17.9 ± 4.4 Å <superscript>2</superscript> ), glucuronidation (N-linked: + 41.7 ± 7.5 Å <superscript>2</superscript> , O-linked: + 38.1 ± 8.9 Å <superscript>2</superscript> ), and glutathione conjugation (+ 49.2 ± 13.2 Å <superscript>2</superscript> ). Consequently, we propose to consider such relative shifts in <superscript>TW</superscript> CCS <subscript>N2, meas</subscript> (rather than absolute values) as well for metabolite assignment/confirmation complementing the conventional approach to associate changes in mass-to-charge (m/z) values between a parent drug and its metabolite(s). Moreover, the comparison of relative shifts in <superscript>TW</superscript> CCS <subscript>N2, meas</subscript> significantly simplifies the mapping of metabolites into metabolic pathways as demonstrated.<br /> (© 2023. The Author(s).)

Details

Language :
English
ISSN :
1618-2650
Volume :
416
Issue :
2
Database :
MEDLINE
Journal :
Analytical and bioanalytical chemistry
Publication Type :
Academic Journal
Accession number :
38040943
Full Text :
https://doi.org/10.1007/s00216-023-05063-1